nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—HTR7—Parkinson's disease	0.299	0.391	CbGaD
Eletriptan—HTR1A—Parkinson's disease	0.229	0.3	CbGaD
Eletriptan—CYP2D6—Parkinson's disease	0.137	0.18	CbGaD
Eletriptan—ABCB1—Parkinson's disease	0.098	0.129	CbGaD
Eletriptan—HTR7—enteric nervous system—Parkinson's disease	0.0075	0.081	CbGeAlD
Eletriptan—HTR7—superior cervical ganglion—Parkinson's disease	0.00718	0.0775	CbGeAlD
Eletriptan—HTR7—myenteric nerve plexus—Parkinson's disease	0.00569	0.0614	CbGeAlD
Eletriptan—HTR7—locus ceruleus—Parkinson's disease	0.00495	0.0535	CbGeAlD
Eletriptan—HTR7—sympathetic nervous system—Parkinson's disease	0.00392	0.0423	CbGeAlD
Eletriptan—HTR1B—telencephalic ventricle—Parkinson's disease	0.00305	0.0329	CbGeAlD
Eletriptan—HTR1D—telencephalic ventricle—Parkinson's disease	0.00295	0.0318	CbGeAlD
Eletriptan—HTR7—pons—Parkinson's disease	0.00285	0.0308	CbGeAlD
Eletriptan—HTR7—autonomic nervous system—Parkinson's disease	0.00263	0.0284	CbGeAlD
Eletriptan—HTR1A—telencephalic ventricle—Parkinson's disease	0.00246	0.0265	CbGeAlD
Eletriptan—HTR7—telencephalic ventricle—Parkinson's disease	0.00235	0.0254	CbGeAlD
Eletriptan—HTR1F—forebrain—Parkinson's disease	0.00194	0.021	CbGeAlD
Eletriptan—HTR7—peripheral nervous system—Parkinson's disease	0.0019	0.0205	CbGeAlD
Eletriptan—HTR1E—brainstem—Parkinson's disease	0.00174	0.0188	CbGeAlD
Eletriptan—HTR1E—forebrain—Parkinson's disease	0.00168	0.0182	CbGeAlD
Eletriptan—HTR7—nerve—Parkinson's disease	0.00148	0.016	CbGeAlD
Eletriptan—HTR1A—hindbrain—Parkinson's disease	0.00116	0.0125	CbGeAlD
Eletriptan—HTR1F—head—Parkinson's disease	0.00111	0.012	CbGeAlD
Eletriptan—HTR7—hindbrain—Parkinson's disease	0.00111	0.012	CbGeAlD
Eletriptan—HTR1F—nervous system—Parkinson's disease	0.00105	0.0114	CbGeAlD
Eletriptan—HTR1F—central nervous system—Parkinson's disease	0.00101	0.011	CbGeAlD
Eletriptan—HTR1E—head—Parkinson's disease	0.000963	0.0104	CbGeAlD
Eletriptan—Naratriptan—MAOA—Parkinson's disease	0.000936	0.117	CrCbGaD
Eletriptan—HTR1E—nervous system—Parkinson's disease	0.000913	0.00985	CbGeAlD
Eletriptan—HTR1E—central nervous system—Parkinson's disease	0.000879	0.00949	CbGeAlD
Eletriptan—HTR1B—brainstem—Parkinson's disease	0.000824	0.0089	CbGeAlD
Eletriptan—HTR1F—brain—Parkinson's disease	0.000805	0.0087	CbGeAlD
Eletriptan—HTR1D—brainstem—Parkinson's disease	0.000798	0.00861	CbGeAlD
Eletriptan—HTR1B—forebrain—Parkinson's disease	0.000795	0.00859	CbGeAlD
Eletriptan—HTR1D—forebrain—Parkinson's disease	0.00077	0.00831	CbGeAlD
Eletriptan—HTR2B—forebrain—Parkinson's disease	0.000716	0.00773	CbGeAlD
Eletriptan—Zolmitriptan—MAOA—Parkinson's disease	0.00071	0.0887	CrCbGaD
Eletriptan—Naratriptan—HTR1A—Parkinson's disease	0.000707	0.0884	CrCbGaD
Eletriptan—HTR1E—brain—Parkinson's disease	0.000698	0.00753	CbGeAlD
Eletriptan—HTR1B—cardiovascular system—Parkinson's disease	0.000672	0.00726	CbGeAlD
Eletriptan—HTR1A—brainstem—Parkinson's disease	0.000665	0.00718	CbGeAlD
Eletriptan—HTR1D—cardiovascular system—Parkinson's disease	0.000651	0.00703	CbGeAlD
Eletriptan—HTR1A—forebrain—Parkinson's disease	0.000642	0.00693	CbGeAlD
Eletriptan—HTR7—brainstem—Parkinson's disease	0.000635	0.00686	CbGeAlD
Eletriptan—CYP2D6—hindbrain—Parkinson's disease	0.00063	0.0068	CbGeAlD
Eletriptan—HTR7—forebrain—Parkinson's disease	0.000613	0.00662	CbGeAlD
Eletriptan—HTR2B—cardiovascular system—Parkinson's disease	0.000606	0.00654	CbGeAlD
Eletriptan—HTR1A—cardiovascular system—Parkinson's disease	0.000543	0.00586	CbGeAlD
Eletriptan—Almotriptan—MAOA—Parkinson's disease	0.000538	0.0672	CrCbGaD
Eletriptan—Zolmitriptan—HTR1A—Parkinson's disease	0.000536	0.067	CrCbGaD
Eletriptan—HTR1B—midbrain—Parkinson's disease	0.000525	0.00567	CbGeAlD
Eletriptan—HTR7—cardiovascular system—Parkinson's disease	0.000519	0.0056	CbGeAlD
Eletriptan—Sumatriptan—MAOA—Parkinson's disease	0.000518	0.0647	CrCbGaD
Eletriptan—HTR1B—spinal cord—Parkinson's disease	0.000512	0.00553	CbGeAlD
Eletriptan—HTR1D—midbrain—Parkinson's disease	0.000508	0.00549	CbGeAlD
Eletriptan—CYP2A6—cerebellum—Parkinson's disease	0.000476	0.00514	CbGeAlD
Eletriptan—HTR1B—head—Parkinson's disease	0.000455	0.00492	CbGeAlD
Eletriptan—HTR7—medulla oblongata—Parkinson's disease	0.000443	0.00478	CbGeAlD
Eletriptan—HTR1D—head—Parkinson's disease	0.000441	0.00476	CbGeAlD
Eletriptan—HTR1B—nervous system—Parkinson's disease	0.000432	0.00466	CbGeAlD
Eletriptan—PTGS1—forebrain—Parkinson's disease	0.000424	0.00458	CbGeAlD
Eletriptan—HTR1A—midbrain—Parkinson's disease	0.000424	0.00458	CbGeAlD
Eletriptan—HTR1D—nervous system—Parkinson's disease	0.000418	0.00451	CbGeAlD
Eletriptan—HTR1B—central nervous system—Parkinson's disease	0.000416	0.00449	CbGeAlD
Eletriptan—HTR1A—spinal cord—Parkinson's disease	0.000413	0.00446	CbGeAlD
Eletriptan—HTR2B—head—Parkinson's disease	0.00041	0.00443	CbGeAlD
Eletriptan—HTR7—midbrain—Parkinson's disease	0.000405	0.00437	CbGeAlD
Eletriptan—HTR1D—central nervous system—Parkinson's disease	0.000402	0.00434	CbGeAlD
Eletriptan—HTR7—spinal cord—Parkinson's disease	0.000395	0.00427	CbGeAlD
Eletriptan—CYP2C9—cardiovascular system—Parkinson's disease	0.000393	0.00424	CbGeAlD
Eletriptan—Sumatriptan—HTR1A—Parkinson's disease	0.000391	0.0489	CrCbGaD
Eletriptan—HTR2B—nervous system—Parkinson's disease	0.000389	0.0042	CbGeAlD
Eletriptan—CYP2A6—brain—Parkinson's disease	0.000386	0.00417	CbGeAlD
Eletriptan—Encainide—CYP2D6—Parkinson's disease	0.000378	0.0473	CrCbGaD
Eletriptan—HTR2B—central nervous system—Parkinson's disease	0.000374	0.00404	CbGeAlD
Eletriptan—HTR1A—head—Parkinson's disease	0.000367	0.00397	CbGeAlD
Eletriptan—CYP2D6—brainstem—Parkinson's disease	0.000361	0.0039	CbGeAlD
Eletriptan—PTGS1—cardiovascular system—Parkinson's disease	0.000358	0.00387	CbGeAlD
Eletriptan—HTR7—head—Parkinson's disease	0.000351	0.00379	CbGeAlD
Eletriptan—CYP2D6—forebrain—Parkinson's disease	0.000348	0.00376	CbGeAlD
Eletriptan—HTR1A—nervous system—Parkinson's disease	0.000348	0.00376	CbGeAlD
Eletriptan—HTR1A—central nervous system—Parkinson's disease	0.000335	0.00362	CbGeAlD
Eletriptan—HTR7—nervous system—Parkinson's disease	0.000333	0.00359	CbGeAlD
Eletriptan—Sumatriptan—DRD2—Parkinson's disease	0.000332	0.0415	CrCbGaD
Eletriptan—Almotriptan—CYP2E1—Parkinson's disease	0.000332	0.0415	CrCbGaD
Eletriptan—HTR1B—brain—Parkinson's disease	0.00033	0.00356	CbGeAlD
Eletriptan—HTR1A—cerebellum—Parkinson's disease	0.000328	0.00354	CbGeAlD
Eletriptan—HTR7—central nervous system—Parkinson's disease	0.000321	0.00346	CbGeAlD
Eletriptan—HTR1D—brain—Parkinson's disease	0.000319	0.00345	CbGeAlD
Eletriptan—HTR7—cerebellum—Parkinson's disease	0.000313	0.00338	CbGeAlD
Eletriptan—HTR2B—brain—Parkinson's disease	0.000297	0.00321	CbGeAlD
Eletriptan—ABCB1—embryo—Parkinson's disease	0.000283	0.00306	CbGeAlD
Eletriptan—Clemastine—CYP2D6—Parkinson's disease	0.000281	0.0351	CrCbGaD
Eletriptan—PTGS1—spinal cord—Parkinson's disease	0.000273	0.00295	CbGeAlD
Eletriptan—HTR1A—brain—Parkinson's disease	0.000266	0.00287	CbGeAlD
Eletriptan—Mesoridazine—DRD3—Parkinson's disease	0.000258	0.0323	CrCbGaD
Eletriptan—HTR7—brain—Parkinson's disease	0.000254	0.00275	CbGeAlD
Eletriptan—ABCB1—forebrain—Parkinson's disease	0.000251	0.00271	CbGeAlD
Eletriptan—Almotriptan—CYP2D6—Parkinson's disease	0.000244	0.0305	CrCbGaD
Eletriptan—PTGS1—head—Parkinson's disease	0.000243	0.00262	CbGeAlD
Eletriptan—PTGS1—nervous system—Parkinson's disease	0.00023	0.00248	CbGeAlD
Eletriptan—PTGS1—central nervous system—Parkinson's disease	0.000222	0.00239	CbGeAlD
Eletriptan—ABCB1—cardiovascular system—Parkinson's disease	0.000212	0.00229	CbGeAlD
Eletriptan—Mesoridazine—HTR1A—Parkinson's disease	0.000211	0.0263	CrCbGaD
Eletriptan—Thioridazine—HTR7—Parkinson's disease	0.000207	0.0259	CrCbGaD
Eletriptan—CYP2D6—head—Parkinson's disease	0.0002	0.00215	CbGeAlD
Eletriptan—CYP3A4—nervous system—Parkinson's disease	0.000192	0.00208	CbGeAlD
Eletriptan—Thioridazine—DRD1—Parkinson's disease	0.000191	0.0239	CrCbGaD
Eletriptan—CYP2D6—nervous system—Parkinson's disease	0.000189	0.00204	CbGeAlD
Eletriptan—CYP3A4—central nervous system—Parkinson's disease	0.000185	0.002	CbGeAlD
Eletriptan—CYP2D6—central nervous system—Parkinson's disease	0.000182	0.00197	CbGeAlD
Eletriptan—ABCB1—medulla oblongata—Parkinson's disease	0.000181	0.00195	CbGeAlD
Eletriptan—Mesoridazine—DRD2—Parkinson's disease	0.000179	0.0223	CrCbGaD
Eletriptan—CYP2D6—cerebellum—Parkinson's disease	0.000178	0.00192	CbGeAlD
Eletriptan—PTGS1—brain—Parkinson's disease	0.000176	0.0019	CbGeAlD
Eletriptan—Sumatriptan—ABCB1—Parkinson's disease	0.000168	0.0209	CrCbGaD
Eletriptan—ABCB1—midbrain—Parkinson's disease	0.000166	0.00179	CbGeAlD
Eletriptan—ABCB1—spinal cord—Parkinson's disease	0.000161	0.00174	CbGeAlD
Eletriptan—Thioridazine—HTR1A—Parkinson's disease	0.000159	0.0199	CrCbGaD
Eletriptan—CYP2D6—brain—Parkinson's disease	0.000145	0.00156	CbGeAlD
Eletriptan—ABCB1—head—Parkinson's disease	0.000144	0.00155	CbGeAlD
Eletriptan—Mesoridazine—HTR2A—Parkinson's disease	0.000138	0.0173	CrCbGaD
Eletriptan—ABCB1—nervous system—Parkinson's disease	0.000136	0.00147	CbGeAlD
Eletriptan—Thioridazine—DRD2—Parkinson's disease	0.000135	0.0169	CrCbGaD
Eletriptan—ABCB1—central nervous system—Parkinson's disease	0.000131	0.00141	CbGeAlD
Eletriptan—Thioridazine—CYP2E1—Parkinson's disease	0.00013	0.0162	CrCbGaD
Eletriptan—ABCB1—cerebellum—Parkinson's disease	0.000128	0.00138	CbGeAlD
Eletriptan—Mesoridazine—CYP2D6—Parkinson's disease	0.000126	0.0158	CrCbGaD
Eletriptan—Thioridazine—HTR2A—Parkinson's disease	0.000104	0.013	CrCbGaD
Eletriptan—ABCB1—brain—Parkinson's disease	0.000104	0.00112	CbGeAlD
Eletriptan—Thioridazine—CYP2D6—Parkinson's disease	9.53e-05	0.0119	CrCbGaD
Eletriptan—HTR1F—Signaling Pathways—HTR2A—Parkinson's disease	1.73e-05	0.000126	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—FGB—Parkinson's disease	1.72e-05	0.000126	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—HTR2A—Parkinson's disease	1.72e-05	0.000126	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HTR1A—Parkinson's disease	1.71e-05	0.000125	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NGF—Parkinson's disease	1.71e-05	0.000125	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—DRD3—Parkinson's disease	1.71e-05	0.000125	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	1.7e-05	0.000124	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TAC1—Parkinson's disease	1.69e-05	0.000123	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.66e-05	0.000121	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—DRD1—Parkinson's disease	1.65e-05	0.000121	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	1.65e-05	0.000121	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ADRBK1—Parkinson's disease	1.64e-05	0.00012	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HTR2A—Parkinson's disease	1.63e-05	0.000119	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ADRBK1—Parkinson's disease	1.63e-05	0.000119	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—APOE—Parkinson's disease	1.6e-05	0.000117	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—DRD3—Parkinson's disease	1.6e-05	0.000117	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	1.6e-05	0.000117	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.59e-05	0.000117	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ADRBK1—Parkinson's disease	1.59e-05	0.000116	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	1.59e-05	0.000116	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—DRD2—Parkinson's disease	1.59e-05	0.000116	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HTR7—Parkinson's disease	1.58e-05	0.000115	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—DRD2—Parkinson's disease	1.58e-05	0.000115	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	1.56e-05	0.000114	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CYP2D6—Parkinson's disease	1.55e-05	0.000113	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ND3—Parkinson's disease	1.54e-05	0.000113	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.54e-05	0.000113	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—DRD2—Parkinson's disease	1.54e-05	0.000113	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HTR7—Parkinson's disease	1.54e-05	0.000113	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.53e-05	0.000112	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CTGF—Parkinson's disease	1.52e-05	0.000111	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—APOE—Parkinson's disease	1.51e-05	0.000111	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ADRBK1—Parkinson's disease	1.5e-05	0.000109	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—INSR—Parkinson's disease	1.48e-05	0.000108	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CYP2D6—Parkinson's disease	1.47e-05	0.000107	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—OMD—Parkinson's disease	1.45e-05	0.000106	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.45e-05	0.000106	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HTR7—Parkinson's disease	1.45e-05	0.000106	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—DRD2—Parkinson's disease	1.45e-05	0.000106	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CTGF—Parkinson's disease	1.44e-05	0.000105	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—DDC—Parkinson's disease	1.43e-05	0.000104	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CYP2E1—Parkinson's disease	1.42e-05	0.000104	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—NQO1—Parkinson's disease	1.4e-05	0.000102	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FGB—Parkinson's disease	1.4e-05	0.000102	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—DDC—Parkinson's disease	1.39e-05	0.000102	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.39e-05	0.000102	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.39e-05	0.000101	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—TH—Parkinson's disease	1.38e-05	0.000101	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.38e-05	0.000101	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—INS—Parkinson's disease	1.37e-05	0.0001	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	1.37e-05	0.0001	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTA4—Parkinson's disease	1.35e-05	9.86e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	1.34e-05	9.81e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CYP2E1—Parkinson's disease	1.34e-05	9.8e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.33e-05	9.74e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IGF2—Parkinson's disease	1.33e-05	9.72e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CYCS—Parkinson's disease	1.33e-05	9.7e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—NQO1—Parkinson's disease	1.33e-05	9.69e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IGF2—Parkinson's disease	1.32e-05	9.65e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.32e-05	9.63e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—DDC—Parkinson's disease	1.31e-05	9.61e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.31e-05	9.6e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—TH—Parkinson's disease	1.31e-05	9.55e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—DDC—Parkinson's disease	1.3e-05	9.52e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	1.3e-05	9.5e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IGF2—Parkinson's disease	1.29e-05	9.45e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—INS—Parkinson's disease	1.29e-05	9.45e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IGF1R—Parkinson's disease	1.29e-05	9.39e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IGF1R—Parkinson's disease	1.28e-05	9.33e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EDN1—Parkinson's disease	1.27e-05	9.28e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EDN1—Parkinson's disease	1.26e-05	9.22e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CYCS—Parkinson's disease	1.25e-05	9.17e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IGF1R—Parkinson's disease	1.25e-05	9.14e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.24e-05	9.07e-05	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.24e-05	9.05e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	1.24e-05	9.03e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.23e-05	8.99e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.21e-05	8.88e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IGF2—Parkinson's disease	1.21e-05	8.88e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.21e-05	8.88e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.21e-05	8.87e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.2e-05	8.79e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.19e-05	8.67e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	1.18e-05	8.59e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	1.18e-05	8.59e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—COMT—Parkinson's disease	1.17e-05	8.59e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IGF1R—Parkinson's disease	1.17e-05	8.58e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—MAOB—Parkinson's disease	1.17e-05	8.58e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—DBH—Parkinson's disease	1.17e-05	8.56e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.17e-05	8.56e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GBA—Parkinson's disease	1.17e-05	8.56e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GSTP1—Parkinson's disease	1.17e-05	8.55e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NGF—Parkinson's disease	1.17e-05	8.53e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—MAOA—Parkinson's disease	1.17e-05	8.53e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	1.16e-05	8.48e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NGF—Parkinson's disease	1.16e-05	8.48e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—HMOX1—Parkinson's disease	1.15e-05	8.43e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.14e-05	8.37e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NGF—Parkinson's disease	1.14e-05	8.3e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.12e-05	8.17e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HTR2A—Parkinson's disease	1.11e-05	8.12e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—COMT—Parkinson's disease	1.11e-05	8.12e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.11e-05	8.1e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ABCB1—Parkinson's disease	1.11e-05	8.09e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.11e-05	8.08e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GSTP1—Parkinson's disease	1.11e-05	8.08e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	1.1e-05	8.07e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—MAOA—Parkinson's disease	1.1e-05	8.06e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.1e-05	8.01e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—HMOX1—Parkinson's disease	1.09e-05	7.97e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	1.08e-05	7.9e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GSTM1—Parkinson's disease	1.07e-05	7.85e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NGF—Parkinson's disease	1.07e-05	7.8e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ABCB1—Parkinson's disease	1.05e-05	7.65e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.04e-05	7.63e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—APOE—Parkinson's disease	1.03e-05	7.55e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GPX1—Parkinson's disease	1.03e-05	7.52e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—APOE—Parkinson's disease	1.03e-05	7.5e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CASP3—Parkinson's disease	1.02e-05	7.46e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GSTM1—Parkinson's disease	1.02e-05	7.43e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	1.02e-05	7.42e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL6—Parkinson's disease	1.01e-05	7.41e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—APOE—Parkinson's disease	1e-05	7.34e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	9.85e-06	7.2e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GPX1—Parkinson's disease	9.73e-06	7.11e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CASP3—Parkinson's disease	9.63e-06	7.04e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL6—Parkinson's disease	9.56e-06	6.99e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	9.52e-06	6.96e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—MTHFR—Parkinson's disease	9.49e-06	6.94e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—APOE—Parkinson's disease	9.44e-06	6.9e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	9.41e-06	6.88e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MAPK8—Parkinson's disease	9.38e-06	6.86e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—MTHFR—Parkinson's disease	8.98e-06	6.56e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	8.94e-06	6.53e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MAPK8—Parkinson's disease	8.85e-06	6.47e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—APOE—Parkinson's disease	8.84e-06	6.46e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—INS—Parkinson's disease	8.82e-06	6.45e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CTGF—Parkinson's disease	8.77e-06	6.41e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—INS—Parkinson's disease	8.76e-06	6.41e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP2D6—Parkinson's disease	8.72e-06	6.38e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NGF—Parkinson's disease	8.65e-06	6.32e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—DDC—Parkinson's disease	8.59e-06	6.28e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—INS—Parkinson's disease	8.58e-06	6.27e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CTGF—Parkinson's disease	8.56e-06	6.26e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—APOE—Parkinson's disease	8.36e-06	6.11e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	8.23e-06	6.02e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	8.17e-06	5.98e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	8.15e-06	5.96e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTA4—Parkinson's disease	8.11e-06	5.93e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NQO1—Parkinson's disease	8.08e-06	5.91e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CTGF—Parkinson's disease	8.07e-06	5.9e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—INS—Parkinson's disease	8.06e-06	5.89e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CTGF—Parkinson's disease	8e-06	5.85e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP2E1—Parkinson's disease	7.98e-06	5.83e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—TH—Parkinson's disease	7.96e-06	5.82e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NQO1—Parkinson's disease	7.89e-06	5.77e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—TH—Parkinson's disease	7.77e-06	5.68e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APOE—Parkinson's disease	7.65e-06	5.59e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYCS—Parkinson's disease	7.65e-06	5.59e-05	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—INS—Parkinson's disease	7.55e-06	5.52e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	7.52e-06	5.5e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYCS—Parkinson's disease	7.46e-06	5.46e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	7.45e-06	5.45e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NQO1—Parkinson's disease	7.43e-06	5.43e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NQO1—Parkinson's disease	7.37e-06	5.39e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—TH—Parkinson's disease	7.33e-06	5.36e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	7.3e-06	5.34e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—TH—Parkinson's disease	7.26e-06	5.31e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MAOB—Parkinson's disease	7.23e-06	5.29e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—INS—Parkinson's disease	7.14e-06	5.22e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYCS—Parkinson's disease	7.03e-06	5.14e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYCS—Parkinson's disease	6.97e-06	5.1e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—COMT—Parkinson's disease	6.77e-06	4.95e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTP1—Parkinson's disease	6.74e-06	4.93e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—MAOA—Parkinson's disease	6.72e-06	4.92e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—HMOX1—Parkinson's disease	6.65e-06	4.86e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—COMT—Parkinson's disease	6.61e-06	4.83e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTP1—Parkinson's disease	6.58e-06	4.81e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CASP3—Parkinson's disease	6.57e-06	4.8e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—MAOA—Parkinson's disease	6.56e-06	4.8e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—INS—Parkinson's disease	6.54e-06	4.78e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL6—Parkinson's disease	6.53e-06	4.77e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	6.53e-06	4.77e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—HMOX1—Parkinson's disease	6.49e-06	4.74e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	6.48e-06	4.74e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	6.39e-06	4.67e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ABCB1—Parkinson's disease	6.38e-06	4.66e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	6.35e-06	4.64e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—COMT—Parkinson's disease	6.23e-06	4.55e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTP1—Parkinson's disease	6.2e-06	4.53e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTM1—Parkinson's disease	6.19e-06	4.53e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—MAOA—Parkinson's disease	6.18e-06	4.52e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—COMT—Parkinson's disease	6.17e-06	4.51e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTP1—Parkinson's disease	6.15e-06	4.49e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—MAOA—Parkinson's disease	6.13e-06	4.48e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—HMOX1—Parkinson's disease	6.11e-06	4.47e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—HMOX1—Parkinson's disease	6.06e-06	4.43e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTM1—Parkinson's disease	6.05e-06	4.42e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	6.04e-06	4.41e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	6e-06	4.39e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	6e-06	4.38e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6—Parkinson's disease	5.99e-06	4.38e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	5.96e-06	4.36e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GPX1—Parkinson's disease	5.93e-06	4.34e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	5.87e-06	4.29e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ABCB1—Parkinson's disease	5.87e-06	4.29e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ABCB1—Parkinson's disease	5.82e-06	4.25e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GPX1—Parkinson's disease	5.79e-06	4.23e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTM1—Parkinson's disease	5.7e-06	4.16e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6—Parkinson's disease	5.65e-06	4.13e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTM1—Parkinson's disease	5.65e-06	4.13e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	5.52e-06	4.03e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—MTHFR—Parkinson's disease	5.47e-06	4e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GPX1—Parkinson's disease	5.46e-06	3.99e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GPX1—Parkinson's disease	5.41e-06	3.95e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	5.37e-06	3.93e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—MTHFR—Parkinson's disease	5.34e-06	3.91e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.27e-06	3.86e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APOE—Parkinson's disease	5.1e-06	3.73e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—MTHFR—Parkinson's disease	5.03e-06	3.68e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—MTHFR—Parkinson's disease	4.99e-06	3.65e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOE—Parkinson's disease	4.97e-06	3.64e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	4.91e-06	3.59e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	4.87e-06	3.56e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NQO1—Parkinson's disease	4.86e-06	3.55e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	4.84e-06	3.54e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TH—Parkinson's disease	4.79e-06	3.5e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOE—Parkinson's disease	4.69e-06	3.43e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOE—Parkinson's disease	4.65e-06	3.4e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYCS—Parkinson's disease	4.6e-06	3.36e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	4.47e-06	3.27e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—INS—Parkinson's disease	4.35e-06	3.18e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—INS—Parkinson's disease	4.25e-06	3.11e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—COMT—Parkinson's disease	4.07e-06	2.98e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.05e-06	2.96e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.04e-06	2.96e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—INS—Parkinson's disease	4e-06	2.93e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4e-06	2.92e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—INS—Parkinson's disease	3.97e-06	2.9e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6—Parkinson's disease	3.85e-06	2.82e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.84e-06	2.8e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6—Parkinson's disease	3.83e-06	2.8e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6—Parkinson's disease	3.75e-06	2.74e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTM1—Parkinson's disease	3.72e-06	2.72e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.57e-06	2.61e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6—Parkinson's disease	3.52e-06	2.58e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.29e-06	2.41e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOE—Parkinson's disease	3.06e-06	2.24e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6—Parkinson's disease	2.86e-06	2.09e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—INS—Parkinson's disease	2.62e-06	1.91e-05	CbGpPWpGaD
